Lorazepam Injection Recalled for Out-of-Specification Impurities and Degradation
Hikma Pharmaceuticals is recalling 82,700 vials of Lorazepam Injection due to failed quality specifications for impurities and degradation. Lot #070096 (expired July 2023) was distributed nationwide.
- Product
- LORAZEPAM — LORAZEPAM (LORAZEPAM)
- Category
- Drug
- Distribution
- Distributed nationwide